ROCKET PHARMACEUTICALS, INC.
For the period ended Jun 30, 2025. Filed Aug 7, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2025 · Filed Aug 7, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Performance Stock Units
The following table summarizes the Company’s PSU activity for thesix months ended June 30, 2025:
| Weighted Average | ||
|---|---|---|
| Number of | Grant Date | |
| Shares | Fair Value | |
| Unvested as of December 31, 2024 | 69,661 | $28.71 |
| Granted | - | - |
| Vested | - | - |
| Forfeited | (34,831) | 28.71 |
| Unvested as of June 30, 2025 | 34,830 | $28.71 |
PSU vesting and expense recognition is based on achievement of specific performance goals within certain time periods. PSU awards that are not achieved within specific time periods are forfeited. No performance goals were probable of achievement as of June 30, 2025, and the time period for one of the performance goals expired during the six months ended June 30, 2025.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.